Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies
NCT: NCT06875102 · RECRUITING
Brief Summary
Unexplained fatigue is a frequent (60-70%) chronic complaint in Sjögren's syndrome (SjS) with a clear unmet therapeutic need, despite the recommendation of adapted physical activity (APA) programs, which are effective and feasible, but only to some extent. Hence, other therapeutic approaches, such as Acupuncture (ACU) or transcutaneous vagal nerve stimulation (tVNS), have been evaluated during the past years, with varying degrees of success in alleviating fatigue. FESSONA has been designed as a randomized controlled monocentric trial, aiming at comparing the effects of 3 different programs on fatigue in SjS: APA alone, APA+ACU and APA+tVNS. Relevant controls will be included as well (sham ACU and simulated tVNS). Multiple fatigue and SjS-related features will be measured before (at inclusion) and after (week 12) the intervention, as well as at week 24 and 48, to evaluate the short- and long-term impact of each program. Tolerance and feasibility will also be evaluated.
Frequently Asked Questions
What is Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies?
Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies is a clinical trial registered under NCT06875102. Current status: RECRUITING.
What is the status of NCT06875102?
The current status of NCT06875102 (Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies) is: RECRUITING.
When did Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies start?
Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies started on 2026-03-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.